2JYA

NMR solution structure of protein ATU1810 from Agrobacterium tumefaciens. Northeast Structural Genomics Consortium target AtR23, Ontario Centre for Structural Proteomics Target ATC1776

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
2	2D 1H-13C HSQC	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	100% D2O	300	7.0	ambient	298
3	3D CBCA(CO)NH	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
4	3D HBHA(CO)NH	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
5	3D HNCO	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
6	3D HNCA	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
7	3D H(CCO)NH	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
8	3D (H)C(CCO)NH	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
9	3D HCCH-TOCSY	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	100% D2O	300	7.0	ambient	298
10	3D HCCH-TOCSY	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	100% D2O	300	7.0	ambient	298
11	3D 1H-15N NOESY	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
12	3D 1H-13C NOESY aliphatic	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
13	3D 1H-13C NOESY aromatic	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
14	2D 1H-15N HSQC(IPAP)	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298
15	3D TROSY-HNCO	0.5 mM [U-13C; U-15N] Atu1810, 10 mM TRIS, 300 mM sodium chloride, 0.1 % sodium azide, 10 mM benzamidine	90% H2O/10% D2O	300	7.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	800
3	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
molecular dynamics		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read
2	refinement	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read
3	data analysis	Sparky		Goddard
4	structure solution	TALOS		Cornilescu, Delaglio and Bax
5	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.